Has a biotech startup secured $80m for its leukemia drug?
A biotech startup has successfully raised $80 million in a Series B financing round, co-led by New Enterprise Associates and DR One, to advance the...
This website uses cookies to improve your experience. We assume you agree, but you can opt out if you wish. Accept More Info